Laura C. Meurer

474 total citations
15 papers, 334 citations indexed

About

Laura C. Meurer is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Laura C. Meurer has authored 15 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Organic Chemistry, 7 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Laura C. Meurer's work include Synthesis and Reactions of Organic Compounds (3 papers), Synthesis and Biological Evaluation (3 papers) and Cancer therapeutics and mechanisms (2 papers). Laura C. Meurer is often cited by papers focused on Synthesis and Reactions of Organic Compounds (3 papers), Synthesis and Biological Evaluation (3 papers) and Cancer therapeutics and mechanisms (2 papers). Laura C. Meurer collaborates with scholars based in United States, United Kingdom and Australia. Laura C. Meurer's co-authors include Wallace T. Ashton, Richard L. Tolman, Malcolm MacCoss, Paul E. Finke, Richard Liou, John Hannah, Helen C. Perry, John D. Karkas, Anjalie Field and Gool F. Patel and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Tetrahedron Letters.

In The Last Decade

Laura C. Meurer

15 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura C. Meurer United States 11 175 144 55 43 39 15 334
Jacob J. Plattner United States 10 171 1.0× 173 1.2× 68 1.2× 41 1.0× 37 0.9× 11 347
Halina T. Serafinowska United Kingdom 14 356 2.0× 372 2.6× 60 1.1× 40 0.9× 40 1.0× 24 672
Jean‐Paul Daris United States 8 130 0.7× 187 1.3× 59 1.1× 36 0.8× 22 0.6× 17 304
Kiran S. Toti United States 12 262 1.5× 171 1.2× 47 0.9× 39 0.9× 20 0.5× 25 475
Genadiy Kalayanov Sweden 9 86 0.5× 226 1.6× 76 1.4× 114 2.7× 30 0.8× 20 387
Frans Janssens Belgium 12 254 1.5× 142 1.0× 75 1.4× 153 3.6× 23 0.6× 21 565
Raymond Hewer South Africa 12 112 0.6× 144 1.0× 78 1.4× 31 0.7× 24 0.6× 27 365
Juliang Zhu United States 11 163 0.9× 117 0.8× 80 1.5× 71 1.7× 12 0.3× 16 382
Wim Schepens Belgium 8 176 1.0× 179 1.2× 31 0.6× 59 1.4× 22 0.6× 10 339
Robert Gomez United States 13 198 1.1× 240 1.7× 65 1.2× 25 0.6× 25 0.6× 21 431

Countries citing papers authored by Laura C. Meurer

Since Specialization
Citations

This map shows the geographic impact of Laura C. Meurer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura C. Meurer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura C. Meurer more than expected).

Fields of papers citing papers by Laura C. Meurer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura C. Meurer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura C. Meurer. The network helps show where Laura C. Meurer may publish in the future.

Co-authorship network of co-authors of Laura C. Meurer

This figure shows the co-authorship network connecting the top 25 collaborators of Laura C. Meurer. A scholar is included among the top collaborators of Laura C. Meurer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura C. Meurer. Laura C. Meurer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Meurer, Laura C., Paul E. Finke, Karen Owens, et al.. (2006). Cyclopentane-based human NK1 antagonists. Part 2: Development of potent, orally active, water-soluble derivatives. Bioorganic & Medicinal Chemistry Letters. 16(17). 4504–4511. 21 indexed citations
2.
Finke, Paul E., Laura C. Meurer, Dorothy Levorse, et al.. (2006). Cyclopentane-based human NK1 antagonists. Part 1: Discovery and initial SAR. Bioorganic & Medicinal Chemistry Letters. 16(17). 4497–4503. 33 indexed citations
3.
Meurer, Laura C., Paul E. Finke, Sander G. Mills, et al.. (2004). Synthesis and SAR of 5,6-diarylpyridines as human CB1 inverse agonists. Bioorganic & Medicinal Chemistry Letters. 15(3). 645–651. 27 indexed citations
4.
Desai, Ranjit C., et al.. (2002). Expeditious synthesis of tri-substituted cyclopentane derivatives. Tetrahedron Letters. 43(26). 4569–4570. 11 indexed citations
5.
Finke, Paul E., Laura C. Meurer, Bryan Oates, et al.. (2001). Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: A proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanes. Bioorganic & Medicinal Chemistry Letters. 11(18). 2469–2473. 31 indexed citations
6.
Meurer, Laura C., et al.. (1995). The synthesis and antibacterial activity of 2-carbolinyl-carbapenems: potent anti-MRSA/MRCNS agents. Bioorganic & Medicinal Chemistry Letters. 5(7). 767–772. 22 indexed citations
7.
MacCoss, Malcolm, Laura C. Meurer, Karst Hoogsteen, et al.. (1993). Synthesis and biological evaluation of nucleosides containing 8‐amino‐imidazo[1,2‐α]pyrazine as an isosteric replacement for adenine. Journal of Heterocyclic Chemistry. 30(5). 1213–1220. 6 indexed citations
8.
Meurer, Laura C., Richard L. Tolman, R Saperstein, et al.. (1993). ChemInform Abstract: Synthesis and Hypoglycemic Activity of Substituted 8‐(1‐Piperazinyl) imidazo(1,2‐a)pyrazines.. ChemInform. 24(20). 1 indexed citations
9.
Meurer, Laura C., Richard L. Tolman, R Saperstein, et al.. (1992). Synthesis and hypoglycemic activity of substituted 8-(1-piperazinyl)imidazo[1,2-a]pyrazines. Journal of Medicinal Chemistry. 35(21). 3845–3857. 35 indexed citations
10.
Ashton, Wallace T., Laura C. Meurer, Richard L. Tolman, et al.. (1992). Renin inhibitors containing C-termini derived from mercaptoheterocycles. Journal of Medicinal Chemistry. 35(11). 2103–2112. 28 indexed citations
11.
Bourne, Nigel, Fernando Bravo, Wallace T. Ashton, et al.. (1992). Assessment of a selective inhibitor of herpes simplex virus thymidine kinase (L-653,180) as therapy for experimental recurrent genital herpes. Antimicrobial Agents and Chemotherapy. 36(9). 2020–2024. 14 indexed citations
12.
Ashton, Wallace T., Laura C. Meurer, Anjalie Field, et al.. (1989). ChemInform Abstract: Synthesis and Antiherpetic Activity of (.+‐.)‐9‐((Z‐2‐(Hydroxymethyl)cyclopropyl)methyl)guanine and Related Compounds.. ChemInform. 20(20). 3 indexed citations
13.
Ashton, Wallace T., Laura C. Meurer, Richard L. Tolman, et al.. (1989). A Potent, Selective, Non-Substrate Inhibitor of HSV-I Thymidine Kinase: (±)-9-[[(Z)-2-(Hydroxymethyl)Cyclohexyl]Methyl]Guanine and Related Compounds. Nucleosides Nucleotides & Nucleic Acids. 8(5). 1157–1158. 15 indexed citations
14.
Ashton, Wallace T., Laura C. Meurer, Anjalie Field, et al.. (1988). Synthesis and antiherpetic activity of (.+-.)-9-[[(Z)-2-(hydroxymethyl)cyclopropyl]methyl]guanine and related compounds. Journal of Medicinal Chemistry. 31(12). 2304–2315. 77 indexed citations
15.
Wicker, Linda S., Wallace T. Ashton, Robert C. Boltz, et al.. (1988). 5-Halo-6-phenyl pyrimidinones and 8-substituted guanosines: Biological response modifiers with similar effects on B cells. Cellular Immunology. 112(1). 156–165. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacob J. Plattner Breakdown of academic impact, for papers by Halina T. Serafinowska Breakdown of academic impact, for papers by Jean‐Paul Daris Breakdown of academic impact, for papers by Kiran S. Toti Breakdown of academic impact, for papers by Genadiy Kalayanov Breakdown of academic impact, for papers by Frans Janssens Breakdown of academic impact, for papers by Raymond Hewer Breakdown of academic impact, for papers by Juliang Zhu Breakdown of academic impact, for papers by Wim Schepens Breakdown of academic impact, for papers by Robert Gomez
Rankless by CCL
2026